Abstract
Background: Long noncoding RNAs (LncRNAs) represent a large category of functional RNA molecules that play a significant role in human cancers. lncRNAs can be gene modulators to affect the biological process of multiple cancers.
Methods: Here, we developed a computational framework that uses the lncRNA-mRNA network and mutations in individual genes of 9 cancers from TCGA to prioritize cancer lncRNA modulators. Our method screened risky cancer lncRNA regulators based on integrated multiple lncRNA functional networks and 3 calculation methods.
Results: Validation analyses revealed that our method was more effective than prioritization based on a single lncRNA network. This method showed high predictive performance, and the highest ROC score was 0.836 in breast cancer. It’s worth noting that we found that 5 lncRNAs scores were abnormally high, and these lncRNAs appeared in 9 cancers. By consulting the literature, these 5 lncRNAs were experimentally supported lncRNAs. Analyses of prioritizing lncRNAs reveal that these lncRNAs are enriched in various cancer-related biological processes and pathways.
Conclusion: Together, these results demonstrated the ability of this method to identify candidate lncRNA molecules and improved insights into the pathogenesis of cancer.
Keywords: computational framework, lncRNA-mRNA network, mutations, cancer lncRNA modulators
Graphical Abstract
[http://dx.doi.org/10.3322/caac.21590] [PMID: 31912902]
[http://dx.doi.org/10.1016/j.cell.2011.02.013] [PMID: 21376230]
[http://dx.doi.org/10.1126/science.1235122] [PMID: 23539594]
[http://dx.doi.org/10.1038/ng.2764] [PMID: 24071849]
[http://dx.doi.org/10.1093/bib/bbv068] [PMID: 26307061]
[http://dx.doi.org/10.1158/0008-5472.CAN-12-2850] [PMID: 23243023]
[http://dx.doi.org/10.1186/s12943-016-0575-6] [PMID: 28069000]
[http://dx.doi.org/10.1038/ncomms6383] [PMID: 25415230]
[http://dx.doi.org/10.1093/nar/gks967] [PMID: 23132350]
[http://dx.doi.org/10.1158/0008-5472.CAN-15-0273] [PMID: 26208906]
[http://dx.doi.org/10.1093/nar/gkt1248] [PMID: 24297251]
[http://dx.doi.org/10.1093/nar/gkw1052] [PMID: 27899615]
[PMID: 23175614]
[http://dx.doi.org/10.1093/nar/gkv1094] [PMID: 26481356]
[http://dx.doi.org/10.1038/nrc1299] [PMID: 14993899]
[http://dx.doi.org/10.1186/1471-2105-12-455] [PMID: 22115179]
[http://dx.doi.org/10.1016/j.ccell.2016.03.010] [PMID: 27070700]
[http://dx.doi.org/10.1039/c2mb25070e] [PMID: 22722759]
[http://dx.doi.org/10.1038/bjc.2014.383] [PMID: 25025966]
[http://dx.doi.org/10.1186/s13045-014-0063-7] [PMID: 25167886]
[http://dx.doi.org/10.1016/j.devcel.2012.12.012] [PMID: 23369715]
[http://dx.doi.org/10.1093/nar/gkw377] [PMID: 27141961]
[http://dx.doi.org/10.1093/nar/gkt1023] [PMID: 24194601]
[http://dx.doi.org/10.1186/s13059-014-0512-1] [PMID: 25517485]
[http://dx.doi.org/10.1016/j.bbagen.2013.10.035] [PMID: 24184936]
[http://dx.doi.org/10.18632/oncotarget.1913] [PMID: 24810858]
[http://dx.doi.org/10.1038/srep10159] [PMID: 25959498]
[http://dx.doi.org/10.1093/nar/gkv1128] [PMID: 26519468]
[http://dx.doi.org/10.1016/j.biocel.2017.09.008] [PMID: 28919047]
[http://dx.doi.org/10.18632/oncotarget.7828] [PMID: 26942882]
[http://dx.doi.org/10.18632/oncotarget.17356] [PMID: 28938549]
[http://dx.doi.org/10.1007/s11060-017-2667-6] [PMID: 29170907]
[http://dx.doi.org/10.1101/gr.1239303] [PMID: 14597658]
[http://dx.doi.org/10.1038/nrg.2015.10] [PMID: 26666209]
[http://dx.doi.org/10.1016/j.bbagrm.2014.08.012] [PMID: 25159663]
[http://dx.doi.org/10.18632/oncotarget.2469] [PMID: 25275300]